Abstract:Highlights • Our findings revealed a significant increase in sympathetic activity, for example, NE levels, in various mouse models of osteoarthritis, including natural aging, medial meniscus instability, and load-induced models. • Notably, alterations in the expression levels of β1-adrenergic receptor and SIRT6 were observed in chondrocytes of naturally aging osteoarthritis mouse models. • Our study highlights the role of sympathetic innervation in driving the transfer of exosomal miR-125 from osteoarthritic chondrocytes. • Our study found that sympathetic innervation leading to the disruption of subchondral bone homeostasis and exacerbation of cartilage damage in aging mice. • These findings shed light on the potential contribution of sympathetic regulation to the pathogenesis of aging-related osteoarthritis. Introduction Osteoarthritis (OA) is a progressive disease that poses a significant threat to human health, particularly in aging individuals: Although sympathetic activation has been implicated in bone metabolism, its role in the development of OA related to aging remains poorly understood. Therefore, this study aimed to investigate how sympathetic regulation impacts aging-related OA through experiments conducted both i n vivo and in vitro. Methods To analyze the effect of sympathetic regulation on aging-related OA, we conducted experiments using various mouse models. These models included a natural aging model, a medial meniscus instability model, and a load-induced model, which were used to examine the involvement of sympathetic nerves. In order to evaluate the expression levels of β1-adrenergic receptor ( Adrβ1 ) and sirtuin-6 ( Sirt6 ) in chondrocytes of naturally aging OA mouse models, we performed assessments. Additionally, we investigated the influence of β1-adrenergic receptor knockout or treatment with a β1-adrenergic receptor blocker on the progression of OA in aging mice and detected exosome release and detected downstream signaling expression by inhibiting exosome release. Furthermore, we explored the impact of sympathetic depletion through tyrosine hydroxylase ( TH ) on OA progression in aging mice. Moreover, we studied the effects of norepinephrine(NE)-induced activation of the β1-adrenergic receptor signaling pathway on the release of exosomes and miR-125 from chondrocytes, subsequently affecting osteoblast differentiation in subchondral bone. Results Our findings demonstrated a significant increase in sympathetic activity, such as NE levels, in various mouse models of OA including natural aging, medial meniscus instability, and load-induced models. Notably, we observed alterations in the expression levels of β1-adrenergic receptor and Sirt6 in chondrocytes in OA mouse models associated with natural aging, leading to an improvement in the progression of OA. Critically, we found that the knockout of β1-adrenergic receptor or treatment with a β1-adrenergic receptor blocker attenuated OA progression in aging mice and the degraded cartilage explants produced more exosome than the nondegraded ones, Moreover, sympathetic depletion through TH was shown to ameliorate OA progression in aging mice. Additionally, we discovered that NE-induced activation of the β1-adrenergic receptor signaling pathway facilitated the release of exosomes and miR-125 from chondrocytes, promoting osteoblast differentiation in subchondral bone. Conclusion In conclusion, our study highlights the role of sympathetic innervation in facilitating the transfer of exosomal miR-125 from osteoarthritic chondrocytes, ultimately disrupting subchondral bone homeostasis and exacerbating cartilage damage in aging mice. These findings provide valuable insights into the potential contribution of sympathetic regulation to the pathogenesis of aging-related OA. Graphical abstract Download : Download high-res image (301KB) <span class="anchor- -Abstract Truncated-

Small non-coding RNAome changes during human chondrocyte senescence as potential epigenetic targets in age-related osteoarthritis

Changes in Small Noncoding RNA Expression during Chondrocyte Senescence

Transcriptomic Changes During the Replicative Senescence of Human Articular Chondrocytes

Single-cell protein activity analysis reveals a novel subpopulation of chondrocytes and the corresponding key master regulator proteins associated with anti-senescence and OA progression

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

Down-regulation of Jun Induces Senescence Through Destabilizing Chromatin in Osteoarthritis Chondrocytes.

Single-cell RNA-seq analysis reveals the progression of human osteoarthritis.

Single-cell analysis of the somatic mutational landscape in human chondrocytes during aging and in osteoarthritis

Senescence in osteoarthritis: from mechanism to potential treatment

miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence

CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications

Cell Cycle-Related Lncrnas and Mrnas in Osteoarthritis Chondrocytes in a Northwest Chinese Han Population

Targeting the senescence-related genes MAPK12 and FOS to alleviate osteoarthritis

Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications

Small Noncoding RNAome Changes During Human Bone Marrow Mesenchymal Stem Cells Senescence In Vitro

Lnc-Samd 14-4 Can Regulate Expression of the COL 1 A 1 and COL 1 A 2 in Human Chondrocytes

Inhibition of cellular communication network factor 1 (CCN1)-driven senescence slows down cartilage inflammaging and osteoarthritis

Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis

lnc-SAMD14-4 can regulate expression of the COL1A1 and COL1A2 in human chondrocytes.

Sympathetic innervation induces exosomal miR-125 transfer from osteoarthritic chondrocytes, disrupting subchondral bone homeostasis and aggravating cartilage damage in aging mice

Reprogramming of lipid secretome in senescent synovial fibroblasts ameliorate osteoarthritis development